Expression_NN
of_IN
transcription_NN
factors_NNS
during_IN
sodium_NN
phenylacetate_NN
induced_VBD
erythroid_JJ
differentiation_NN
in_IN
K562_NN
cells_NNS
._.

During_IN
15_CD
days_NNS
of_IN
treatment_NN
of_IN
K562_NN
cells_NNS
with_IN
sodium_NN
phenylacetate_NN
,_,
we_PRP
observed_VBD
an_DT
increase_NN
in_IN
the_DT
cellular_JJ
hemoglobin_NN
concentration_NN
with_IN
a_DT
similar_JJ
increase_NN
in_IN
the_DT
expression_NN
of_IN
gamma-globin_NN
mRNA_NN
._.

Morphological_JJ
studies_NNS
demonstrated_VBD
characteristic_JJ
features_NNS
of_IN
erythroid_JJ
differentiation_NN
and_CC
maturation_NN
._.

At_IN
the_DT
same_JJ
time_NN
there_EX
was_VBD
no_DT
change_NN
in_IN
the_DT
level_NN
of_IN
expression_NN
of_IN
the_DT
cell_NN
surface_NN
antigenes_NNS
CD33_NN
,_,
CD34_NN
,_,
CD45_NN
,_,
CD71_NN
and_CC
glycophorin_NN
A_NN
._.

Likewise_RB
,_,
the_DT
level_NN
of_IN
expression_NN
of_IN
the_DT
erythroid_JJ
transcription_NN
factors_NNS
GATA-1_NN
,_,
GATA-2_NN
,_,
NF-E2_NN
,_,
SCL_NN
and_CC
RBTN2_NN
,_,
all_DT
expressed_VBN
in_IN
untreated_JJ
K562_NN
cells_NNS
,_,
did_VBD
not_RB
increase_VB
during_IN
sodium_NN
phenylacetate_NN
induced_VBD
erythroid_JJ
differentiation_NN
._.

The_DT
expression_NN
of_IN
the_DT
nuclear_JJ
factors_NNS
Evi-1_NN
and_CC
c-myb_NN
,_,
known_VBN
to_TO
inhibit_VB
erythroid_JJ
differentiation_NN
,_,
did_VBD
not_RB
decrease_VB
._.

We_PRP
conclude_VBP
that_IN
sodium_NN
phenylacetate_NN
treatment_NN
of_IN
K562_NN
cells_NNS
increases_VBZ
gamma-globin_NN
mRNA_NN
and_CC
induces_VBZ
cell_NN
maturation_NN
as_IN
judged_VBN
by_IN
morphology_NN
without_IN
affecting_VBG
the_DT
expression_NN
of_IN
the_DT
erythroid_JJ
transcription_NN
factors_NNS
,_,
some_DT
of_IN
which_WDT
are_VBP
known_VBN
to_TO
be_VB
involved_VBN
in_IN
the_DT
regulation_NN
of_IN
beta-like_JJ
globin_NN
genes_NNS
._.

